Stay updated on Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has updated the reference for the study on crizotinib versus chemotherapy in advanced ALK-positive lung cancer, removing an erratum note and updating the version number from v2.15.0 to v2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:51:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed trial descriptions and inclusion criteria for a clinical trial on Non-Small Cell Lung Cancer, while adding new collaborators and a revision number.
    Difference
    14%
    Check dated 2025-04-16T01:39:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-08T20:11:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T14:55:06.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has added the name 'Endeavor Health' while removing references to 'NorthShore University HealthSystem' and a notice about NLM-NCBI services experiencing heavy traffic.
    Difference
    0.8%
    Check dated 2025-03-03T22:21:26.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T09:38:15.000Z thumbnail image

Stay in the know with updates to Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.